Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 44.70p
   
  • Change Today:
      0.000p
  • 52 Week High: 67.60
  • 52 Week Low: 12.50
  • Currency: UK Pounds
  • Shares Issued: 287.07m
  • Volume: 644,335
  • Market Cap: £128.32m
  • RiskGrade: 479

Futura Medical sees 'good progress' despite regulatory delays

By Iain Gilbert

Date: Monday 24 Jun 2019

LONDON (ShareCast) - (Sharecast News) - Pharmaceutical company Futura Medical told investors at its annual general meeting on Monday that it had continued to make "good progress" in developing and commercialising its pipeline of product opportunities despite regulatory delays to the advancement of its pain relief gel.
Futura's novel topical pain relief gel TPR100 saw the UK Medicines and Healthcare products Regulatory Agency raise a number of questions requiring additional lab work to be conducted but has also received expressions of interest from a number of parties requesting the group expand its geographical reach.

Elsewhere, the AIM-listed group said it remained "on track" to deliver headline data from its first European Phase 3 study on MED2005, a topical gel for erectile dysfunction, by the end of 2019 - with planning for a second, confirmatory Phase 3 study already underway.

The second study will incorporate a US patient cohort, which Futura expects to facilitate regulatory filing in the US, and will be informed by the receipt and analysis of the first Phase 3 data.

Chairman John Clarke said: "We continue to make good progress in the development and commercialisation of our pipeline of product opportunities.

"We look forward to updating the market on Futura's developments during 2019, which I expect to be a year of very significant progress for the company."

As of 0925 BST, Futura shares had dipped 6.15% to 30.50p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 44.70p
Change Today 0.000p
% Change 0.00 %
52 Week High 67.60
52 Week Low 12.50
Volume 644,335
Shares Issued 287.07m
Market Cap £128.32m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.64% below the market average57.64% below the market average57.64% below the market average57.64% below the market average57.64% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average
Price Trend
92.27% above the market average92.27% above the market average92.27% above the market average92.27% above the market average92.27% above the market average
72.88% above the sector average72.88% above the sector average72.88% above the sector average72.88% above the sector average72.88% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 18-Jun-2021

Time Volume / Share Price
16:28 369 @ 44.33p
16:24 3,000 @ 44.33p
16:19 1,323 @ 44.50p
16:19 226 @ 44.40p
16:19 2,022 @ 44.50p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page